https://www.selleckchem.com/pr....oducts/crenolanib-cp
Trial Registry ( ChiCTR1800019551 ). Registered 18 November 2018. In Japan, 55.5% of breast cancer survivors (BCSs) are of working age, so various perspectives regarding return to work (RTW) after cancer diagnosis need to be considered. Therefore, this study aimed to clarify the risk factors for resignation and taking sick leave (SL) among BCSs in continued employment at the time of diagnosis. A web-based retrospective cross-sectional survey was conducted on BCSs using data from a 2018 Japanese national research project (En